Literature DB >> 26576043

Osmolarity affects matrix synthesis in the nucleus pulposus associated with the involvement of MAPK pathways: A study of ex vivo disc organ culture system.

Pei Li1, Yibo Gan1, Yuan Xu2, Songtao Li1, Lei Song1, Sukai Li1, Huijuan Li1, Qiang Zhou1.   

Abstract

Matrix homeostasis within the nucleus pulposus (NP) is important for disc function. Unfortunately, the effects of osmolarity on NP matrix synthesis in a disc organ culture system and the underlying mechanisms are largely unknown. The present study was to investigate the effects of different osmolarity modes (constant and cyclic) and osmolarity levels (hypo-, iso-, and hyper-) on NP matrix synthesis using a disc organ culture system and determine whether ERK1/2 or p38MAPK pathway has a role in this process. Porcine discs were cultured for 7 days in various osmotic media, including constant hypo-, iso-, hyper-osmolarity (330, 430, and 550 mOsm/kg, respectively) and cyclic-osmolarity (430 mOsm/kg for 8 h, followed by 550 mOsm/kg for 16 h). The role of ERK1/2 and p38MAPK pathways were determined by their inhibitors U0126 and SB202190 respectively. The expression of SOX9 and downstream aggrecan and collagen II, biochemical content, and histology were used to assess NP matrix synthesis. The findings revealed that NP matrix synthesis was promoted in iso- and cyclic-osmolarity cultures compared to hypo- or hyper-osmolarity culture although the level of matrix synthesis in cyclic-osmolarity culture did not reach that in iso-osmolarity culture. Further analysis suggested that inhibition of the ERK1/2 or p38MAPK pathway in iso- and cyclic-osmolarity cultures reduced NP matrix production. Therefore, we concluded that the effects of osmolarity on NP matrix synthesis depend on osmolarity level (hypo-, iso-, or hyper-) and osmolarity mode (constant or cyclic), and the ERK1/2 and p38MAPK pathways may participate in this process.
© 2015 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 34:1092-1100, 2016. © 2015 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  ERK1/2; matrix; nucleus pulposus; osmolarity; p38MAPK

Mesh:

Year:  2015        PMID: 26576043     DOI: 10.1002/jor.23106

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  6 in total

1.  Pericellular heparan sulfate proteoglycans: Role in regulating the biosynthetic response of nucleus pulposus cells to osmotic loading.

Authors:  Carly M Krull; Jordan Rife; Brett Klamer; Devina Purmessur; Benjamin A Walter
Journal:  JOR Spine       Date:  2022-06-03

2.  High-magnitude compression accelerates the premature senescence of nucleus pulposus cells via the p38 MAPK-ROS pathway.

Authors:  Pei Li; Gang Hou; Ruijie Zhang; Yibo Gan; Yuan Xu; Lei Song; Qiang Zhou
Journal:  Arthritis Res Ther       Date:  2017-09-18       Impact factor: 5.156

3.  Overexpression of Aquaporin-3 Alleviates Hyperosmolarity-Induced Nucleus Pulposus Cell Apoptosis via Regulating the ERK1/2 Pathway.

Authors:  Zetong Zhang; Chen Zhao; Ruijie Zhang; Yiyang Wang; Yanzhu Hu; Qiang Zhou; Pei Li
Journal:  Pain Res Manag       Date:  2022-04-09       Impact factor: 2.667

4.  Resveratrol increases nucleus pulposus matrix synthesis through activating the PI3K/Akt signaling pathway under mechanical compression in a disc organ culture.

Authors:  Xiaorui Han; Xiaoming Leng; Man Zhao; Mei Wu; Amei Chen; Guoju Hong; Ping Sun
Journal:  Biosci Rep       Date:  2017-11-23       Impact factor: 3.840

5.  Osteogenic protein-1 attenuates nucleus pulposus cell apoptosis through activating the PI3K/Akt/mTOR pathway in a hyperosmotic culture.

Authors:  Yan Yang; Xiyang Wang; Zheng Liu; Xiao Xiao; Wenkai Hu; Zhicheng Sun
Journal:  Biosci Rep       Date:  2018-12-14       Impact factor: 3.840

6.  Stiffness of photocrosslinkable gelatin hydrogel influences nucleus pulposus cell propertiesin vitro.

Authors:  Panpan Xu; Jingjing Guan; Yu Chen; Hui Xiao; Tianhao Yang; Hengheng Sun; Nan Wu; Changchun Zhang; Yingji Mao
Journal:  J Cell Mol Med       Date:  2020-12-02       Impact factor: 5.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.